Grace Therapeutics, Inc. GRCE
1.94 USD 0.00 0.00%
At close
2.05 +0.11 +5.66%
Pre-market · Nov 2, 7:36 AM ET
- YTD
- -43.93%
- 1 year
- -39.18%
- Open
- 1.95
- Prev close
- 1.94
- Mkt cap
- 40.81M
- Vol
- 85.94K
- Avg vol
- 138.44K
- EPS
- -1.17
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.87
- High
- 1.98
- Forward P/E
- -2.90
- Beta
- 1.51
- Short ratio
- 3.25
- Inst. own
- 21.39%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 10, 2025
- 50-d avg
- 3.44
- 200-d avg
- 3.04
- 1y target
- 10.44
5D chart
Chart tools
Chart is warming up
The five-day price history for GRCE has not been loaded yet. Try again in a moment.
Altman Z-Score
6.01 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
P/E -9.9×
P/S 0.0×
P/B 1.2×
P/FCF -8.6×
EV/EBITDA -5.4×
EV/Sales 0.0×
FCF Yield -11.6%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -12.2%
ROIC -14.1%
ROA -11.7%
Revenue 0.0%
Operating Income 53.4%
EPS (diluted) 58.4%
Free Cash Flow 40.5%
Current Ratio 8.1×
Quick Ratio 8.1×
Debt / Equity 0.0×
Net Debt / EBITDA 1.5×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2026-03-31
